ContextVision will have exclusive rights to the scanning cohort and access to anonymized associated clinical data - with cleared and structured histopathological descriptions, diagnosis and outcome data - for the defined patient cohorts and all commercial rights from output based on the data.The agreement gives ContextVision an opportunity to create AI-based decision support tools that will help doctors make more accurate treatment decisions. Today, many cancer patients suffer from life impairing side effects from treatments they did not need while other patients do not get treatment which is necessary.
ContextVision is pleased to announce that Fredrik Palm will become CEO of the Company as of April 1, 2019. Fredrik Palm has since 2012 been the Company's V.P. of sales and was instrumental in growing sales significantly under his tenure. Fredrik Palm will succeed Anita Tollstadius, who in October 2018 announced her intent and wish to step down to dedicate more time to her family.
March 11st, 2019 – An article about ContextVision has been published in the Norwegian business newspaper Finansavisen (in Norwegian only). Please find a link here. For further information, please contact ContextVision’s CEO, Fredrik Palm, at +46 76 870 25 43
Today ContextVision held a company presentation at Danske Bank's Small & Mid Cap Seminar in Stockholm, Sweden.CEO Anita Tollstadius gave an update of the company's development and shared the company's future direction.